|By PR Newswire||
|January 21, 2014 01:42 PM EST||
CHICAGO, Jan. 21, 2014 /PRNewswire/ -- Cour Pharmaceutical Development Company, Inc., a biopharmaceutical company, announced today the publication of new data in Science Translational Medicine that shows the potential of its proprietary therapy, known as Immune Modifying Nanoparticles (IMP), to reduce inflammation and promote tissue repair and regeneration in patients who have suffered a heart attack. More than 750,000 patients suffer from heart attacks & related complications each year.
When animal models were injected with IMPs after a heart attack, the size of the heart lesions were reduced by 50 percent allowing the heart to pump significantly more blood. IMP treatment showed reduced inflammation and promoted regeneration in all models tested.
"This is the first therapy that specifically targets a key driver of the inflammation that occurs after a heart attack," said Daniel Getts, Chief Scientific Officer at Cour. "There is no other therapy on the horizon that can protect the heart from the aggressive immune cell infiltration that causes so much damage."
Originally discovered in the laboratory of Professor Nicholas King, at the University of Sydney, the particles are proprietary compositions based on poly-lactic-co-glycolic acid, a biocompatible and biodegradable substance already approved by the Food and Drug Administration for use in a range of therapeutics.
"IMP therapy represents a significant step toward the next generation of immune modulating agents," said John J. Puisis, CEO of Cour. He added, "Our first priority as a company is to bring IMPs to patients who've suffered acute myocardial infarction, where we see a tremendous opportunity to improve clinical outcomes and quality of life."
The therapy also showed efficacy in numerous other inflammatory models, specifically in West Nile Virus, Encephalitis, Peritonitis, Multiple Sclerosis, and Inflammatory Bowel Disease - all with the potential to benefit patients suffering from these inflammatory diseases.
Getts and King are corresponding authors on the paper, which was published January 15, 2014 in Science Translational Medicine.
For more information, visit www.courpharma.com
SOURCE Cour Pharmaceutical Development Company, Inc.
What does it look like when you have access to cloud infrastructure and platform under the same roof? Let’s talk about the different layers of Technology as a Service: who cares, what runs where, and how does it all fit together. In his session at 18th Cloud Expo, Phil Jackson, Lead Technology Evangelist at SoftLayer, an IBM company, spoke about the picture being painted by IBM Cloud and how the tools being crafted can help fill the gaps in your IT infrastructure.
Oct. 1, 2016 10:00 AM EDT Reads: 3,194
SYS-CON Events announced today that Niagara Networks will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Niagara Networks offers the highest port-density systems, and the most complete Next-Generation Network Visibility systems including Network Packet Brokers, Bypass Switches, and Network TAPs.
Oct. 1, 2016 10:00 AM EDT Reads: 591
DevOps at Cloud Expo – being held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA – announces that its Call for Papers is open. Born out of proven success in agile development, cloud computing, and process automation, DevOps is a macro trend you cannot afford to miss. From showcase success stories from early adopters and web-scale businesses, DevOps is expanding to organizations of all sizes, including the world's largest enterprises – and delivering real results. Am...
Oct. 1, 2016 10:00 AM EDT Reads: 4,657
What happens when the different parts of a vehicle become smarter than the vehicle itself? As we move toward the era of smart everything, hundreds of entities in a vehicle that communicate with each other, the vehicle and external systems create a need for identity orchestration so that all entities work as a conglomerate. Much like an orchestra without a conductor, without the ability to secure, control, and connect the link between a vehicle’s head unit, devices, and systems and to manage the ...
Oct. 1, 2016 10:00 AM EDT Reads: 503
For basic one-to-one voice or video calling solutions, WebRTC has proven to be a very powerful technology. Although WebRTC’s core functionality is to provide secure, real-time p2p media streaming, leveraging native platform features and server-side components brings up new communication capabilities for web and native mobile applications, allowing for advanced multi-user use cases such as video broadcasting, conferencing, and media recording.
Oct. 1, 2016 10:00 AM EDT Reads: 3,314
Oct. 1, 2016 09:45 AM EDT Reads: 2,762
Oct. 1, 2016 09:45 AM EDT Reads: 825
Oct. 1, 2016 09:15 AM EDT Reads: 1,671
Oct. 1, 2016 09:00 AM EDT Reads: 2,940
Oct. 1, 2016 08:45 AM EDT Reads: 5,504
Oct. 1, 2016 08:30 AM EDT Reads: 2,507
Oct. 1, 2016 08:30 AM EDT Reads: 3,415
Oct. 1, 2016 08:00 AM EDT Reads: 1,313
Oct. 1, 2016 08:00 AM EDT Reads: 2,273